Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

BRAF mutation testing in colorectal cancer.

Sharma SG, Gulley ML.

Arch Pathol Lab Med. 2010 Aug;134(8):1225-8. doi: 10.1043/2009-0232-RS.1. Review.

PMID:
20670148
2.

BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.

Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM.

Dis Colon Rectum. 2012 Feb;55(2):128-33. doi: 10.1097/DCR.0b013e31823c08b3.

PMID:
22228154
3.

Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.

Benlloch S, Payá A, Alenda C, Bessa X, Andreu M, Jover R, Castells A, Llor X, Aranda FI, Massutí B.

J Mol Diagn. 2006 Nov;8(5):540-3.

4.

KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay.

Jakubauskas A, Griskevicius L.

Arch Pathol Lab Med. 2010 Apr;134(4):620-4. doi: 10.1043/1543-2165-134.4.620.

PMID:
20367313
5.

Detection of BRAF V600E mutation by pyrosequencing.

Tan YH, Liu Y, Eu KW, Ang PW, Li WQ, Salto-Tellez M, Iacopetta B, Soong R.

Pathology. 2008 Apr;40(3):295-8. doi: 10.1080/00313020801911512.

PMID:
18428050
6.

Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability.

Kakar S, Deng G, Sahai V, Matsuzaki K, Tanaka H, Miura S, Kim YS.

Arch Pathol Lab Med. 2008 Jun;132(6):958-64. doi: 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2.

PMID:
18517279
7.

Somatic BRAF-V600E mutations in familial colorectal cancer.

Vandrovcova J, Lagerstedt-Robinsson K, Påhlman L, Lindblom A.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2270-3.

8.

[BRAF mutation in colorectal serrated lesions].

Zhou ZY, Han Y, Wang LP.

Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3411-4. Chinese.

PMID:
19159571
9.

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr.

J Med Genet. 2004 Sep;41(9):664-8.

10.

Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.

Krol LC, 't Hart NA, Methorst N, Knol AJ, Prinsen C, Boers JE.

Eur J Cancer. 2012 May;48(7):1108-15. doi: 10.1016/j.ejca.2012.02.054. Epub 2012 Mar 23.

PMID:
22446020
11.

Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.

Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1831-9. doi: 10.1158/1055-9965.EPI-10-0055. Epub 2010 Jun 22.

12.

Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.

Pichler M, Balic M, Stadelmeyer E, Ausch C, Wild M, Guelly C, Bauernhofer T, Samonigg H, Hoefler G, Dandachi N.

J Mol Diagn. 2009 Mar;11(2):140-7. doi: 10.2353/jmoldx.2009.080100. Epub 2009 Feb 12.

13.

Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.

Jensen LH, Dysager L, Lindebjerg J, Kølvrå S, Byriel L, Crüger DG.

Eur J Cancer. 2010 Jul;46(10):1823-8. doi: 10.1016/j.ejca.2010.03.016. Epub 2010 Apr 21.

PMID:
20417091
14.

Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.

Kadiyska TK, Konstantinova DV, Atanasov VR, Kremensky IM, Mitev VI.

Cancer Detect Prev. 2007;31(3):254-6. Epub 2007 Jun 12.

PMID:
17566669
15.

Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.

Noda H, Kato Y, Yoshikawa H, Arai M, Togashi K, Nagai H, Konishi F, Miki Y.

J Exp Clin Cancer Res. 2006 Jun;25(2):235-42.

PMID:
16918136
16.

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.

BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.

17.

Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.

Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY.

Cancer Res. 2002 Nov 15;62(22):6451-5.

18.

Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.

Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo AM, Monti F, Saragoni L, Amadori D.

J Cell Physiol. 2005 Aug;204(2):484-8.

PMID:
15702478
19.

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.

Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE.

Clin Cancer Res. 2010 Feb 1;16(3):790-9. doi: 10.1158/1078-0432.CCR-09-2446. Epub 2010 Jan 26.

20.

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

Fransén K, Klintenäs M, Osterström A, Dimberg J, Monstein HJ, Söderkvist P.

Carcinogenesis. 2004 Apr;25(4):527-33. Epub 2003 Dec 19.

PMID:
14688025

Supplemental Content

Support Center